Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Flunarizine→

Flunarizine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
52468-60-7
Molecular formula
C26H26F2N2
Molecular weight
404.5 g/mol
Drug class
Selective calcium-entry blockerpiperazine derivative with H1-antihistamine activity
Mechanism of action
Reduces excessive transmembrane calcium entry and cellular calcium overload; it also has calmodulin-binding, histamine H1-blocking and sedative properties.
Indications / reported uses
  • Prevention of migraine attacks
  • Treatment of vertigo of central or peripheral origin in jurisdictions where authorised; use may be limited by depressive and extrapyramidal adverse effects

Sources: NLM MeSH — Flunarizine · PubMed clinical and pharmacological review · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Flunarizine Environmental Risk Assessment (ERA) (the Flunarizine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.